We are live on ! Find out more
GGI

Godsey & Gibb Inc Portfolio holdings

AUM $1.22B
1-Year Est. Return 27.93%
This Fund
S&P 500
This Quarter Est. Return
-0.72%
1 Year Est. Return
+27.93%
3 Year Est. Return
+78.89%
5 Year Est. Return
+79.48%
10 Year Est. Return
+248.77%
AUM
$1B
AUM Growth
-$43.8M
Cap. Flow
-$17M
Cap. Flow %
-1.7%
Top 10 Hldgs %
29.71%
Holding
444
New
13
Increased
38
Reduced
99
Closed
76

Top Buys

Rank Stock Value
1
STT icon
State Street
STT
+$19.3M
2
AAPL icon
Apple
AAPL
+$1.02M
3
MRK icon
Merck
MRK
+$987K
4
SWK icon
Stanley Black & Decker
SWK
+$795K
5
AMGN icon
Amgen
AMGN
+$606K

Top Sells

Rank Stock Value
1
BCE icon
BCE
BCE
+$15.9M
2
ADM icon
Archer Daniels Midland
ADM
+$15.8M
3
ORCL icon
Oracle
ORCL
+$1.39M
4
IBM icon
IBM
IBM
+$958K
5
AVGO icon
Broadcom
AVGO
+$942K

Sector Composition

Rank Sector Weight
1 Technology 22.82%
2 Financials 16.18%
3 Industrials 12.57%
4 Healthcare 11.75%
5 Utilities 10.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMC icon
201
Vulcan Materials
VMC
$36.5B
$27.3K ﹤0.01%
106
RSG icon
202
Republic Services
RSG
$64.5B
$27.2K ﹤0.01%
135
-25
-16% -$5.18K
SUM
203
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$26.7K ﹤0.01%
528
IWR icon
204
iShares Russell Mid-Cap ETF
IWR
$56.7B
$26.5K ﹤0.01%
300
IAU icon
205
iShares Gold Trust
IAU
$66B
$26.2K ﹤0.01%
530
IGV icon
206
iShares Expanded Tech-Software Sector ETF
IGV
$14.1B
$26K ﹤0.01%
260
VNQ icon
207
Vanguard Real Estate ETF
VNQ
$38.8B
$25.9K ﹤0.01%
+291
New +$27.5K
BMY icon
208
Bristol-Myers Squibb
BMY
$131B
$25.7K ﹤0.01%
455
PFE icon
209
Pfizer
PFE
$149B
$25.4K ﹤0.01%
959
-53
-5% -$1.44K
XT icon
210
iShares Future Exponential Technologies ETF
XT
$3.91B
$25.2K ﹤0.01%
423
DTM icon
211
DT Midstream
DTM
$13.6B
$24.9K ﹤0.01%
250
ELV icon
212
Elevance Health
ELV
$84.9B
$24.2K ﹤0.01%
66
-20
-23% -$8.37K
SWKS icon
213
Skyworks Solutions
SWKS
$10.1B
$23.8K ﹤0.01%
268
-225
-46% -$20.4K
XLF icon
214
State Street Financial Select Sector SPDR ETF
XLF
$58.4B
$23.6K ﹤0.01%
489
-70
-13% -$3.38K
SCHI icon
215
Schwab 5-10 Year Corporate Bond ETF
SCHI
$11.4B
$23.4K ﹤0.01%
1,062
CARR icon
216
Carrier Global
CARR
$52.7B
$23.3K ﹤0.01%
341
-135
-28% -$10.2K
SLV icon
217
iShares Silver Trust
SLV
$29.8B
$23K ﹤0.01%
875
VRT icon
218
Vertiv
VRT
$106B
$22.7K ﹤0.01%
200
MPC icon
219
Marathon Petroleum
MPC
$84B
$22.6K ﹤0.01%
162
FDX icon
220
FedEx
FDX
$74.7B
$22.5K ﹤0.01%
80
XLV icon
221
State Street Health Care Select Sector SPDR ETF
XLV
$42.4B
$22.4K ﹤0.01%
163
-155
-49% -$22.7K
EOG icon
222
EOG Resources
EOG
$71.4B
$22.1K ﹤0.01%
180
VTI icon
223
Vanguard Morningstar Total Stock Market ETF
VTI
$680B
$22K ﹤0.01%
76
VWO icon
224
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$21.6K ﹤0.01%
490
EUFN icon
225
iShares MSCI Europe Financials ETF
EUFN
$4.26B
$21.5K ﹤0.01%
921

Similar funds

Godsey & Gibb Inc's Q4 2024 Portfolio in Review

As of Q4 2024, Godsey & Gibb Inc held 444 positions worth $1B, down 4.2% from $1.05B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Godsey & Gibb Inc's Q4 2024 filing shows 13 new, 38 increased, 99 reduced and 76 closed positions. Its largest new stake was State Street: 203,480 shares worth $20M. The largest sale was BCE, an estimated $15.9M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.

  • Godsey & Gibb Inc's largest Q4 2024 buy was State Street: 203,480 shares worth $20M.
  • Godsey & Gibb Inc added most to Apple in Q4 2024, an estimated $1.02M increase.
  • Godsey & Gibb Inc's biggest Q4 2024 reduction was BCE, cutting an estimated $15.9M.
  • Godsey & Gibb Inc fully exited Regeneron Pharmaceuticals in Q4 2024, selling an estimated $137K.
  • Godsey & Gibb Inc's ten largest holdings make up 30% of its $1B portfolio in Q4 2024.
  • Godsey & Gibb Inc opened 13 new positions and closed 76 in Q4 2024.
  • Godsey & Gibb Inc's portfolio value fell 4.2% quarter-over-quarter to $1B.

Based on Godsey & Gibb Inc's 13F filing for Q4 2024, filed 14 Jan 2025.